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ABSTRACT 
The cell surface receptor for/3-nerve growth factor was used as a probe to study the 
development of embryonic chick sensory ganglia. The ganglia were shown to lose 
their  responsiveness  to  nerve growth  factor  in  vitro between  14  and  16  days  of 
embryonic age. This loss occurred by a decrease in the magnitude of the maximum 
biological  response,  not  by  a  shifting  of the  response  to higher  concentrations. 
Binding  assays  for  the  E-nerve  growth  factor  receptor,  using  ~2SI-radiolabelled 
/~-nerve growth  factor, were performed with cells from sensory ganglia 8,  12,  14, 
16,  18, and 21 days of age. The assays revealed a twofold increase in the number of 
receptor sites per ganglion  between  8 and  14 days and a  sixfold drop between  14 
and  16 days of embryonic life. Neither increase nor decrease was accompanied by a 
large change in the affinity of the receptor for the protein. Together with the results 
of  the  bioassay,  the  data  show  that  the  loss  of  biological  responsiveness  is 
correlated with and may be due to a loss of the cells' ability to bind/~-nerve growth 
factor. Correlation of the results of the binding assays with the known ontogeny of 
the  chick  embryo  provides  a  hint  at  the  role  of nerve  growth  factor  in  normal 
development. 
Nerve growth factor (NGF) is a protein endowed 
with the ability to stimulate the hypertrophy and 
hyperplasia of responsive  sympathetic and embry- 
onic  sensory  ganglia.  The  protein  chemistry  of 
NGF  has been extensively  studied.  This includes 
the elucidation of the primary amino acid sequence 
of mouse submaxillary gland NGF isolated either 
as 2.5S NGF (1, 2) or ~NGFL That NGF plays a 
role in peripheral nervous system development and 
maintenance is virtually certain (17, 20). NGF, for 
example,  has  been  found  in  the  serum  of  all 
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vertebrates tested,  from  teleost  fish  to  man.  Its 
biological potency from any one source is similar 
when  measured with responsive  tissues  from vari- 
ous  species.  Furthermore,  the  targets  of  NGF 
action  are  very  specific  (i.e.,  sympathetic  and 
embryonic sensory ganglia) and antiserum made to 
purified NGF destroys the developing sympathetic 
nervous  system  of  newborn  rats  and  mice  and 
markedly impairs sympathetic function in adults. 
Recent work has been aimed at elucidating the 
mechanism of action  of NGF.  Experiments with 
tissue grown in vitro have demonstrated that, with 
the exception of increasing glucose oxidation, most 
cellular  anabolic  processes  are  stimulated  over 
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requires  protein  synthesis  but  not  RNA synthesis 
(24).  At the molecular ievel, it is now known  that 
the first interaction of NGF with responsive cells is 
with  a  cell-surface  receptor,  the  latter  being  de- 
fined by that  fraction of [x251]NGF which binds to 
cells or membrane fractions and which is displace- 
able by native NGF. 
Frazier  et  al.  (9)  have  shown  that  Sepharose- 
bound  NGF (Sepharose,  Pharmacia  Fine Chemi- 
cals, Inc., Piscataway,  N. J.) is capable of eliciting 
fiber outgrowth from sensory ganglia.  Herrup and 
Shooter  (16)  measured  directly  the  binding  of 
[~25I]~NGF to  its  receptor on dissociated  sensory 
ganglion cells. This work demonstrated  that  both 
the  levels  of  binding  of  [~25I]flNGF  and  the 
biological response  of the cells varied with  [~*5I]- 
BNGF  concentration  in  the  same  way.  Chemical 
modification  of the  protein  resulted  in  a  parallel 
loss of both the biological activity and the affinity 
of the derivative for the receptor.  In addition,  the 
specific  binding  of [~25I]/~NGF  could  not  be  dis- 
placed  by  proteins  such  as  cytochrome  c  or 
proinsulin, nor could it be found on cells unrespon- 
sive to NGF such as liver cells. Banerjee et al. (3) 
have  observed  binding  of  a  similar  nature  to  a 
microsomal fraction from the sympathetic ganglia 
of rabbits.  More recently, Frazier et al. (10), using 
a  solid-phase  iodination  technique  to  prepare 
[~2~I]NGF,  presented  evidence  for  high  affinity 
binding  of  NGF  to  a  membrane  and  cellular 
fraction from sympathetic ganglia of chick, rat, or 
rabbit  and  sensory  ganglia  from  chick  embryos. 
However, the  specific  binding  they  observed  did 
not  show saturation  at  concentrations  up  to  10 -8 
M,  indicating  populations  of  receptors  of  Iower 
affinity,  and  it  was  also  inhibited  up  to  20%  by 
appropriate  concentrations  of  insulin.  Although 
the steps subsequent to binding are not known, the 
NGF  receptor does  not  operate  through  modula- 
tion of cAMP concentration  (I i). 
The specific binding assay is a direct measure of 
the  cell's  ability  to  bind  NGF  to  its  receptor  (a 
molecular form of "recognition") and  it has  been 
used  in  the current  study  to expiore the develop- 
ment of chick sensory ganglia.  It is known that, as 
the embryo deveiops, the sensory ganglia lose their 
responsiveness to NGF in tissue culture (20).  The 
work  described  here  demonstrates  that  the  cells' 
loss of responsiveness to flNGF is accompanied by 
a  loss of the cells' ability to bind [~25I]flNGF. 
MATERIALS  AND  METHODS 
Buffers 
All binding  assays were done in a modified version of 
Gey's balanced  salts  solution  (GBS) (12)  in  which  the 
concentrations of phosphate salts were raised to those of 
a 25 mM buffer (pH 7.4). The NaCI content (8.0 g/liter 
in the original) was  reduced  to 6.35 g/liter to maintain 
constant ionic strength. Dextrose and all other salts were 
maintained  at  their  original  concentrations.  This  new 
buffer is referrr  to as phosphate-buffered Gey's (PBG). 
NGF and Other Proteins 
BNGF was isolated according to the methods of Varon 
et al. (27)  and  Smith et  al.  (25).  High specific  activity 
[12sI]~NGF was prepared as described previously (16). It 
was  stored at 4~  in 0.2%  acetic acid with  1.0 mg/ml 
bovine serum albumin (Metrix Instrument Co., Houston, 
Texas) to protect it from radiation damage. 
Collagen was extract•d  from rat tail tendons and used 
to coat 22  ￿  22-mm coverslips by a modification of the 
methods of Ehrman and Gey (8) and  Bornstein  (5). 
,4 nimal Materials 
Fertilized eggs were obtained  from  Kimbr  Farms, 
Fremont, Calif. Eggs were from White Leghorn chickens 
and were storexl in an incubator (Modr  no. 252, James 
Mfg.  Div.,  Fort  Atkinson,  Wis.) at  38~  with  turning 
every 2 h. 
Mice, from whose submaxillary glands the/~NGF was 
isolated,  were  obtained  from  Simonsr  Laboratories, 
Gilroy,  Calif. The  mice were  60-day  old  males of the 
Swiss Webster strain. 
Bioassay for NGF Activity 
The  assays  were pr  as describr  by  Herrup 
and  Shooter  (16).  Dorsal  root  ganglia  were  removed 
from chick embryos incubated 8,  12, 14, 16, and  18 days 
and  stored  separatr  in  plastic pr  dishes  in  chilled 
GBS.  A  single  set  of dilutions  of BNGF  in GBS was 
prepared,  ranging  in  concentrations  from  0.3  to  300 
ng/ml. For each concentration,  15.0 ml of dilution were 
made up and 3.0 ml were dispr  to each of five plastic 
pr  dishes (no. 3001, Falcon Plasties, Dir. of BioQuest, 
Oxnard,  Calif.) with a  collagen-coated coverslip in the 
bottom. One set of dilutions was used for each age. Five 
ganglia were  removr  from the pool and  added  to each 
dilution of the set. A]'ter 60 min at room tempr  the 
ganglia had  settled  and  begun  attachment.  The dishes 
were then transferred to a 37~  humidified incubator and 
incubated overnight in air. The foUowing day, the growth 
of neurites from the ganglia was scorexi on an arbitrary 
scale from 0 to 5. 
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All  assays  were  done  in  PBG  which  was  filtered 
through a  0.2-pm  filter (Nalge Co.,  Nalgene  Labware 
Div.,  Rochester,  N.  Y.)  to  remove  any  particles  that 
might bind ['61]~NGF.  Ganglia were dissected as for 
the bioassay, except that sterility was not observed. The 
pooled ganglia were  washed  twice  in 5.0 ml  PBG  and 
resuspended a  third time in only enough liquid for the 
assay and cell counts.  The ganglia were dissociated by 
drawing them  in  and  out  of a  5.0-tal  pipet.  Care  was 
taken  during  this  procedure  to  avoid  bubbling  air 
through the cell suspension, as this created a froth which 
invariably ied to high levels of cr  damage. The use of 
enzymes or chelating agents to aid in dissociation of the 
ganglia  was  specifically  avoided.  The  teil  suspensions 
thus  obtained  contained,  almost  entirely,  single  cells. 
Cell debris remaining after dissociation was minimal and 
was removed by centrifugation at 500 rpm for 5 sec. The 
nature  of this debris  is  important since if certain cell 
populations are selectively lost during dissociation, arti- 
facts may be obtained wbich would obscure the experi- 
mental  results.  At  all  ages,  a  small percentage of the 
ganglia resist dissociation, usually when a length of the 
distal  or  proximal  root  is  dissected  with  the  ganglia. 
Most of the ganglia (90-95%), however, are completely 
dissociated to single cells.  The debris which is removed 
is thus usually whole ganglia and not small pieces of all 
ganglia. On this basis, the cell suspensions used for these 
experimr  are representative of the composition of the 
ganglia of different ages and not enriched with one popu- 
lation of cells or anotber. This is borne out by phase-con- 
trast examination of the cell suspension which reveals no 
selective loss of any one class of cells.  After removal of 
the debris, cell counts were  done in a  hemocytometer. 
Cell  viability,  as  determined  by  trypan  blue  (Grand 
Island  Biological Co.,  Grand  Island, N.  Y.) exclusion, 
was 85-100%. Cell concentrations ranged from 2 to 15 ￿ 
10  y  cells/ml.  The  binding  assay  was  performed  as 
described  previously  (16).  After  incubation  of  [t26I]- 
BNGF  and  cells,  the  latter  were  freed  from  unbound 
[12q]BNGF by sedimentation through a two step sucrose 
gradient in a Beckman microfuge tube (Beckman Instru- 
ments Inc., Spinco Div.,  Palo Alto, Calif.).  Both peUet 
and supernate were counted and the results expressed as 
pg ~ffNGF bound per  105 cells.  For each concentration, 
total and  nonspecific binding, the latter determined in 
the  presence of  10 pg/ml nonradioactive BNGF,  were 
measured.  Only  specific  binding  values,  calculated  as 
the  difference  between ~total and  nonspecific  binding, 
are  reported  here.  Nonspecific  binding  was  approxi- 
mately of the same order of magnitude for the teils from 
all the ganglia of different ages. 
RESULTS 
The Biological Response of  Sensory Ganglia 
to NGF during Development 
Thougb there is agreement that the ability of the 
sensory ganglia to  respond to  NGF  disappears in 
older chick embryos,  the exact  time limits of this 
phenomenon  have  not  been  weil  defined.  Winick 
and Greenberg (30)  reported  that no neurite out- 
growth  could  be  detected  in  sensory  ganglia  re- 
moved from embryos younger than 7 days or older 
than  13 days of incubation.  In contrast,  Banks et 
al. (4) found responses from ganglia as young as 5 
days  and  as  old  as  16  days  of  embryonic  life. 
Larrabee  et  al.  (as  quoted  by  Jacobson  [18]) 
observed no response of the ganglia to NGF  after 
16-17  days.  Some  of  this  variation  might  stem 
from  differences  in  incubation  conditions  or  the 
initial condition of the eggs. The effects of embryo 
age  on  NGF  responsiveness  have  tberefore  been 
reexamined  using  dorsal  root  ganglia  removed 
from  chicks incubated 8,  12,  14,  16,  and  18 days 
under the conditions used to obtain the ganglia for 
the  binding  assays.  All  the  bioassays  were  done 
using aliquots from a single set of~NGF  dilutions. 
The results of these assays are shown in  Fig.  1. 
Ganglia from 8- to  I4-day old embryos showed 
peak neurite outgrowth in the concentration range 
between  3  and  10  ng/ml  ~NGF.  Ganglia  from 
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FIGUrE  1  Bioassay  of dorsai  root  ganglia  from  em- 
bryos of various ages.  Dorsal root ganglia from 8- (0), 
12- (O),  14- (t"l), 16- (A), and 18- (I) day old chiek em- 
bryos were grown on collagen-coated coverslips at 37~ 
in the  presen~ of various concentrations of ~NGF  in 
GBS.  After 24 h, the resulting halo of nerve fibers was 
scored  on  an  arbitrary  scale  from  0  to  5.  Each  point 
represents the mean of five ganglia. 
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activity in the same concentration range, but the 
level of response was much reduced. Of 48 ganglia 
assayed from  16-day embryos, only three showed 
neurite  outgrowth  which  rated  scores  of  1.0  or 
more.  By  18  days  of  incubation,  the  ganglia 
showed  no  response  to  the  presence  of flNGF. 
These  results  confirm  the  reports  of the  loss  of 
sensory responsiveness of NGF.  In addition, they 
establish that this loss or  at around  16 days of 
embryonic life under  the  conditions used  in  this 
investigation. 
Specific  Binding of BNGF 
During Development 
In light of these results the binding assay for the 
BNGF receptor was used to examine the receptor 
properties  during  this  developmental  sequence. 
The  ability to  measure,  directly, the  binding  of 
[~2q]BNGF to the ceils ailows the determination of 
whether the loss of responsiveness in the bioassay 
is correlated with a  change in the cells' ability to 
bind BNGF or whether there is some other mecha- 
nism, orte or several steps subsequent to the initial 
binding step, which is blocked. 
The binding assays were performed in a manner 
identical to that used previously (16). Ganglia from 
embryos  of  several  of  the  different  ages  were 
assayed twice. In these instances a different prep- 
aration of [~2q]flNGF was used  as weil as a dif- 
ferent set of eggs. The close coincidence of these 
duplicate  experiments  demonstrates  the  repro- 
ducibility  of  the  binding  assay.  The  resuits  are 
compiled in Fig. 2. 
The  binding curve  for  8-day embryo ganglion 
celis saturated at a level of specific binding around 
30 pg [t2q]/SNGF per 105 ganglion cells (Fig. 2 A). 
This number  is the total specific binding capacity 
of the  cells.  Half-saturation  was  reached  at  7-8 
ng/ml which corresponds to the apparent dissocia- 
tion constant, Kp, and is a measure of the affinity 
of the receptor for [~~51]BNGF. 
The  binding curve for  12-day embryo ganglion 
celis (Fig. 2  B) was virtually identical to that for 
8-day cells. The concentration at which half-satu- 
ration  was  reached  was  unchanged  and  the  total 
specific  binding  capacity  was  around  26  pg/105 
cells.  The  binding  curve  for  cells  from  14-day 
embryo ganglia (Fig. 2 C) was slightly, though not 
significantly, different. In two experiments, the Ko 
varied from 5.4 to 7.7  x  10 -1~ M  (14-20 ng/ml). 
This  is two  to  three  times the  values for  8-  and 
12-day  embryo  ganglion  cells. The  total specific 
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FIGURE 2  Effects  of  Embryo  age  on  the  saturation 
curve  of the BNGF  receptor.  The  specific binding  of 
[~~q]BNGF to dissociated dorsal root ganglion cells was 
measured  as a  function  of concentration  using ganglia 
from 8-, 12-, 14-, 18-, and 21-day embryos. For several of 
these age groups, two experiments were done. These are 
distinguished by open (O) or closed (0) circles. All points 
represent means Of three experiments. Bars represent one 
SEM. 
binding capacity also increased to 36 pg/105 cells, 
about  one-tbird higher than  at the younger ages. 
Neither  of these  changes  was significant statisti- 
cally, given the errors indicated in Fig. 2. 
Cells  from  16-day  embryo  ganglia  showed  a 
marked change in the characteristics of the binding 
curve (Fig. 2 D). The total specific binding capac- 
ity dropped  to  6  pg/105  cells, a  four- to  sixfold 
drop compared to the cells from earlier embryos. 
This  change  is  revealing since these ganglia also 
are the first to show a decrease in BNGF respon- 
siveness in the bioassay (Fig. 1). The binding curve 
for  18-day embryo ganglion cells (Fig. 2  E) was 
similar to that for cells from  16-day embryos with 
a total specific binding capacity of 4 pg/105 cells. 
By  21  days, the  specific binding  of the  ganglion 
cells  was  close  to  zero,  with  the  total  specific 
binding capacity down to about 2 pg/106 cells (Fig. 
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ganglion cells at saturation therefore change dur- 
ing the course of development. The data have been 
plotted as a function of embryonic age, using both 
the total specific binding per  105 cells (Fig. 3 A) 
and per ganglion (Fig. 3 B). The binding per  105 
cells falls about sixfold from its average value up to 
14 days of embryonic age to the value at 16 days of 
age.  The  total  specific  binding per  ganglion in- 
creases about twofold between 8 and  14 days and 
then falls about fourfold between 14 and 16 days of 
embryonic age.  The decrease  in binding capacity 
occurs  at  the  same  stage  of development as  the 
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FIGURE 3  Total specific binding capacity ofdorsal root 
ganglion cells as a function of embryo age. The satura- 
tion levels of the  curves in Fig. 2,  normalized to  l0  s 
ganglion cells (Fig. 3 A) or to one dorsal root ganglion 
(Fig.  3  B),  are  plotted here for  each age  of embryo 
examined. 
decrease  in  NGF  responsiveness of  the  sensory 
cells (Fig.  I). 
It is unlikely that the decrease in total specific 
binding capacity after 14 days of embryonic age is 
the  result  of  a  change  in  receptor  affinity  as 
measured by the concentration needed to achieve 
half-saturation of the receptor sites (Ko). Although 
the  curves  in  Fig.  2  D-F  have  been  drawn  to 
saturate within the range of concentrations exam- 
ined and to reach half-saturation at concentrations 
comparable to those in Fig. 2 A-C, the data are not 
sufficiently  precise  to  rule  out  curves  with  a 
positive slope which  saturate at higher concentra- 
tions. If, however, the saturation curve for  18-day 
embryo ganglion cells were to actually reach levels 
of 30 pg/105 cells instead of the observed 4 pg/105 
cells,  Michaelis-Menton kinetic assumptions indi- 
cate  that  the  Ko  would  be  no  less  than  1,500 
ng/ml.  Binding  of  this  nature  would  not  be 
detected  with  the  current assay,  due to  the  high 
ratio  of nonspecific to  specific  binding. The  fact 
that the observed change in binding is not due to 
such a change in KD is supported by the results of 
the bioassay. An increase in Ko would mean that, 
at sufficiently high concentrations of NGF, max- 
imum fiber outgrowth could be stimulated in the 
cultured ganglia. That  this is  not so  is shown  in 
Fig.  1.  The  peak  of biological response  flattens 
with  increasing devetopmental age  (as  would  be 
expected  from  a  decreasing number of receptors 
with a constant Kp) rather than shifting to higher 
concentrations (as  would  be expected  for  a  con- 
stant number of receptors with increasing Kp's). 
Orte difference between the binding assays and 
the  bioassay  is  the  presence  of  residual  specific 
binding  to  the  18-  and  21-day  old  embryonic 
sensory cells at ages where the whole ganglia show 
no neurite outgrowth in response to added NGF. 
The  morphology  of  the  older  ganglia,  however, 
provides a clue to this discrepancy. As the embryo 
develops,  the  sensory ganglia contain more con- 
nective tissue and are enveloped in a tough capsule. 
It is possible that, if the neurite outgrowth in the 
older ganglia is restricted to only a  few neurons, 
the growing fibers would be  unable to  penetrate 
this  capsule.  Experiments  in  which  ganglionic 
dissociates in culture are used (13, 29) are required 
to resolve  this point. 
DISCUSSION 
The identification and characterization of the cell 
surface receptor for NGF (3,  10, 16) have provided 
new evidence on the mechanism of action of NGF. 
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strates that NGF prepared from mouse submaxil- 
lary gland displays similar high affinity binding to 
receptors on chick, rat, or rabbit sympathetic and 
chick sensory cells. This extends the observations 
of the interspecies potency of NGF and speaks to 
the  constancy  of the  essential properties of both 
the  receptor  and  the  NGF  protein  in  evolution. 
The  present  study  demonstrates  that  the  NGF 
receptor  itself  offers  a  sensitive  probe  for  the 
exploration of the development of the  peripheral 
sensory nervous system. 
One important question which has to be consid- 
ered in the interpretation of the binding data is the 
effect of the changing cellular composition of the 
ganglia during  deveiopment.  Fig.  3  A  represents 
the  effects  of  developmental  age  on  the  total 
specific binding capacity of  l0  s sensory ganglion 
celis. This method of normalization (per 105 cells) 
makes no allowance for the changing contribution 
which the cells of any orte  type make to the total 
binding.  It is possible, for example, that the cells 
responsible for  the  specific binding  of NGF  are 
recovered in  lower yields in  the dissociates of the 
oider ganglia  compared  to  those  of the  younger 
ganglia. The work of Varon and Raiborn (28) has 
already emphasized  tbat  many  factors affect the 
cell yield in the dissociation of chick embryo dorsal 
root gangiia. While the present data do not speak 
directly to this question, it should be noted that the 
total  cell  yields,  40,000;  64,000;  73,000;  and 
100,000  cells per ganglion  for  8,  14,  16,  and  18 
day  old  embryos,  were  roughly  comparable  to 
those  obtained in other studies (7,  28); that  little 
cellular debris was  present in  the ganglionic dis- 
sociates  and  that  the  nature  of this  debris  was 
such  that  no  selective loss  of any  orte  cell type 
was obseved. 
With  respect  to  the  sensory  ganglion  itself, 
Levi-Montalcini and  Levi  (21)  have  shown  that 
there is first a hypertrophy of the cells. Whereas at 
8  days  in  embryo  most  neurons  in  the  ganglia 
average  5-10  ~tm  in  diameter,  by  19  days  most 
neurons are larger than 10-15 um and over half are 
more than 20 um in diameter. In addition, there is 
an  increase  in  cell  numbers.  Neuronal  division, 
however, slows by 8 days and is finished by 9 days 
(14). The increase in cell numbers, therefore, must 
be due entirely to nonneuronal elements (i.e., glial 
cells).  This  is  in  agreement  with  the  work  of 
Pannese et al. (23) who found that the number of 
glia associated with a neuron was directly propor- 
tional  to  the  surface  area  of the  neuron.  These 
developmental  changes  could  greatly  affect  the 
interpretation of the binding assays. Il, for exam- 
ple,  the  receptors  for  BNGF  are  found  on  the 
neurons,  then  the  large  drop  seen  in  the  total 
binding capacity per  l0  5 cells between  14 and  16 
days may merely be a reflection of a change in the 
percentage of neurons. Since the number of nerve 
cells per ganglion is not changing during the time 
period examined (14),  recalculating the results of 
Fig. 3 A  on the basis of pg total specific binding 
per  ganglion  should  normalize  the  binding  to  a 
fixed number of neurons. These results are shown 
in  Fig. 3  B. The data show that the drop in total 
binding capacity between  14  and  16 days is real 
and  independent  of the  altered cellular composi- 
tion. 
The  results shown  in  Fig. 3 when compared to 
those obtained in the bioassay (Fig.  I) lead to the 
conclusion  that  the  change  of the  chick  embryo 
sensory cells from an NGF-responsive to an NGF- 
unresponsive  state,  between  14  and  18  days  in 
embryo,  is  accompanied  by  a  decrease  in  the 
specific binding of NGF to their cell surfaces. This 
decrease  could  result  from  a  reduction  in  the 
number  of functional  NGF  receptors on  the cell 
bodies by increased  receptor turnover  or from  a 
masking of a relatively constant number of recep- 
tors  through  changes  in  cell  surface  mac- 
romolecules. Other possibilities also exist. What- 
ever mechanism is involved, it is therefore possible 
that  the  cells cease  to  respond  to  NGF  (in  the 
bioassay and  therefore  perhaps  also  in  vivo) be- 
cause tbey either cease to bind it altogether or do 
so in insufficient amounts. The timing of this event 
can  be  compared  to  the  known  morphological 
development  of the  neurons  in  the  sensory gan- 
glion.  The  neuronal  population  is heterogeneous 
and has been divided, on the basis of morphology, 
into  two  groups:  the  large  ventrolateral  (V-L) 
neurons and the smaller medio-dorsal (M-D) cells 
(14). The patterns of development of these two cell 
types differ as weil. A  detailed description of this 
phenomenon  has  been  given  by  Levi-Montalcini 
and  Levi (21)  and  Hamburger  and  Levi-Montal- 
cini (14).  The differentiation of the large V-L cells 
begins at about 2.5 days of incubation. By 5 days- 
the  tips  of the  growing  axons  have  reached  the 
dermis and by 8 days the ceUs form a homogene- 
ous,  fully differentiated group  of neurons  on  the 
V-L  aspect  of the  ganglion.  After 8  days,  these 
ceiis change very little except to gradually increase 
in  size  and  assume  their  characteristic  pseudo- 
unipolar form. 
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until late in development.  At 8 days they are still 
smali,  undifferentiated  cells,  which  will not  stain 
with silver. It is only the presence of a diffuse Nissl 
substance  and  the morphology of the nucleus that 
allow these cells to be characterized as neuroblasts. 
Beginning at 9-10 days, silver staining is observed 
in these cells along with the outgrowth of neurofi- 
brils. By  12 days, increasing numbers of small cells 
demonstrate this differentiation. From  12 days on, 
there is progressive differentiation of the M-D cells 
as  weil  as  a  considerable  increase  in  size.  Both 
M-D  and  V-L  cells grow conspicuously  up  to  15 
days.  From  15  days  to  hatching,  it  is  no  Ionger 
possible to recognize two distinctly separate popu- 
lations,  The  decreased  NGF  binding  to  the  cell 
bodies  of  the  sensory  ganglion  cells  therefore 
correlates almost precisely with the completion of 
the  differentiation  of  the  M-D  neurons.  This 
correlation  strengthens  the  previous  suggestion 
(20)  that  NGF functions in the organism,  at least 
in  part,  in  conjunction  with  the differentiation  of 
these  cells,  and  it  is  significant  to  note  that  the 
binding  of NGF  decreases  after differentiation  is 
complete,  rather  than  soon  after  its  beginning. 
The  implication  is  that  NGF  may  be  needed 
throughout  the differentiation  process,  not just at 
its  initiation.  At  the  moment,  there  is  only  in- 
direct evidence that  the  receptors  in the ganglion 
are  on neuronal  cell bodies.  This comes from the 
finding  (10)  that  the  bindings  of both  NGF  and 
a-bungarotoxin,  the latter to the acetylcholine re- 
ceptor,  fractionate  with  the  same  membrane 
fragments in two separation  systems.  More direct 
evidence  will  require  the  use  of  cell  separation 
techniques.  It  has  been  assumed  that  the  NGF 
which  reacts  with  the  responsive cells in  the  sen- 
sory  (and  sympathetic)  ganglia  was  derived from 
the  circulation.  The  recent  findings  that  mouse 
dorsal root ganglionic glial cells can replace NGF 
in  supporting  attachment  and  survival of neurons 
from  the  same ganglia  (6)  and  that  the causative 
agent supplied by the glia is functionally and anti- 
genically similar to NGF (31) raise the interesting 
possibility that these cells also supply NGF to the 
ganglion. 
Although  the  cell  body  NGF  receptors  in  the 
chick  sensory  ganglia  largely  disappear  or  are 
masked  by  21  days in embryo,  NGF continues to 
reach  the neurons  in the ganglia by an  alternative 
route. This route is by a  retrograde flow from the 
nerve terminals back  to the cell body (15).  Retro- 
grade transport  of NGF has been demonstrated  in 
sympathetic and sensory fibers, and it continues in 
both in adult animals (26). The source of this NGF 
may  be  the  effector  organs  themselves since  it  is 
known  that  rat  irides  (19)  and  fibroblasts  (22) 
produee  NGF.  Little  is  yet  known  about  the 
development  of the  receptor  sites  on  or  near  the 
nerve  terminals  which  presumably  initiate  this 
retrograde flow. 
This  research  was  supported  by  United  States  Public 
Health Service research grants from the National Insti- 
tute of Neurological Diseases and Stroke (NS 04270) and 
National Science Foundation Grant GB 31982. 
Received for publication  40ctober  1974, and in revised 
form 27 June 1975. 
REFERENCES 
1.  ANGELE'rTI,  R.  H.,  D.  MERCANTI, and  R.  A. 
BRADSHAW. 1973. Amino acid sequences of mouse 
2.5S nerve growth factor. I. Isolation and charac- 
terization of the soluble tryptic and chymotryptic 
peptides.  Biochemistry.  12:90-100. 
2.  ANGELETTI, R.  H.,  M. A. HERMODSON, and  R. A. 
BR~,DSHAW. 1973. Amino acid sequences of mouse 
2.5S nerve growth factor. Il. Isolation and charac- 
terization  of the thermolytic and  peptic peptides 
and  the complete covalent structare.  Biochemis- 
try. 12:t00-115. 
3.  BANEgJEE, S.  P., S.  H.  SNYDER, P.  CUATRECASAS, 
and  L. A. GREENE. 1973. Binding of nerve growth 
factor receptor in sympathetic ganglia. Proc. Natl. 
Acad. Sei.  U. S. A. 70:2519-2523. 
4.  BANKS, B. E. C., D.  V.  BANTHROPE, A.  R.  BERRY, 
H. S.  DAVIES, S.  DOONAN, D.  MARGARET, L. R. 
SaIPOLINt, and C. A. VEgNO,~. 1968. The prcpara- 
tion  of nerve growth  factor from snake  venoms. 
Biochem.  J.  108:157-158. 
5.  BOgNSTEtN,  M. B. 1958. Reconstituted rat-tail colla- 
gen used as substrate for tissue cultures on cover- 
slips  in  Maximow  slides  and  roller tubes.  Lab. 
Invest.  7:134-137. 
6.  BURNHAM, P. A., C. RAIBOgN, and S. VARON. 1972. 
Replacement of nerve growth factor by ganglionic 
non-neuronal  cells  for  the  survival  in  vitro  of 
dissociated  ganglionic neurons.  Proc. Natl. Acad. 
Sci.  U. S. A. 69:3556-3560. 
7.  BUgNHaM, P. A., and S. VAgo.~. 1974. Biosynthetic 
activities of dorsal  root ganglia in  vitro  and  the 
influence of nerve growth factor. Neurobiol.  (Bio- 
ehem. Morphol.) 4:57- 70. 
8.  EHgM/~N. R.  L.,  and  G. O. GEY. 1956. Growth  of 
cells on a transparent  gel of reconstituted rat-tail 
collagen. J. Natl. Cancer Inst.  16:1375  1404. 
9.  FgAZlER, W. A., L. F. BOYD, and R. A. BRADSHAW. 
1973.  Interaction  of  nerve  growth  factor  with 
124  THE  JOURNAL OF  CELL BIOLOGY . VOLUME 67,  1975 surface membranes: biological competence of in- 
solubilized  nerve growth factor. Proc. Natl. Acad. 
Sci. U. S. A. 70:2931-2935. 
10.  FRAZIER,  W. A., L. F. BORD, and R. A. BRAOSHAW. 
1974.  Properties  of the  specific binding  of  ~2Sl 
nerve growth factor to responsive peripheral neu- 
rons. J. Biol.  Chem. 249:5513-5579. 
1  I.  FRAZIER, W. A., C. E. OHLENDORF, L. F. BOYO, L. 
ALOE, E.  M. JOHNSON, J.  A.  FERRENDELLI, and 
R. A.  BRADSHAW. 1973. Mechanism of action of 
nerve  growth factor and  cyclic  AMP on  neurite 
outgrowth  in  embryonic chick  sensory  ganglia: 
demonstration  of  independent  pathways  of 
stimulation.  Proc.  Natl.  Acad.  Sci.  U.  S.  A. 
70:2448-2452. 
12.  GEr, G. O., and M. K. GEr.  1936. The maintenance 
of human normal cells and tumor cells in continu- 
ous culture.  I.  Preliminary report:  cultivation  of 
mesoblastic tumors and  normal tissue and  notes 
on  methods  of  cultivation.  Amer.  J.  Cancer. 
27:45 -76. 
13.  GREENE, L.  A.,  1974.  A  dissociated  cell  culture 
bioassay for nerve growth factor. Neurobiol.  (Bio- 
chem. Morphol.) 4:286-292. 
14.  HAMBURGER, V.,  and  R.  LEvl-MO~TALCINL t949. 
Proliferation, differentiation and degeneration in 
the  spinal  ganglia  of  the  chick  embryo  under 
normal and experimental conditioos. J. Exp. Zool. 
111:457-501, 
15.  HENDRY, I. A., K. STOCKEL, H. T￿9  and L. L. 
IVERSEN. 1974. The retrograde axonal transport of 
nerve growth factor. Brain Res. 68:103-12 I. 
16.  HERRUP, K., and E.  M. SHOOTER. 1973. Properties 
of the BNGF  receptor of avian  dorsal root gan- 
glia.  Proc.  Natl.  Acad.  Sci.  U.  S.  A.  70:3884- 
3888. 
17.  HERRUP, K.,  R. STICKGOLD, and E.  M. SHOOTER. 
1974. The  role  of the nerve growth factor in the 
development of sensory and sympathetic ganglia. 
Ann. N.  Y. Acad. Sci. 228:381-392. 
18.  JACOBSON, M.,  1970. Developmental Neurobiology 
Holt,  Rinehart  and  Winston,  Inc.,  New  York, 
N.Y. 
19.  JOUNSOr~, D. G., S.  D. SILBERSTEIN, 1.  HANBAUER, 
and  1. J.  KOPIN. 1972. The role  of nerve growth 
factor  in  the  ramification  of sympathetic nerve 
fibers into the rat iris in organ culture.  J. Neuro- 
chem.  19:2025 2029. 
20.  LEvI-MoN'fALr  R., and P. U. ANGELETTI. 1968. 
Nerve growth factor. Physiol.  Rev. 48:534-569. 
21.  LEvI-MONTALr  R.,  and  G.  LEVl. 1943. Re- 
cberches quantitatives sur la marche due proces~us 
de differentiation des neurones dans les ganglion 
spinaux  de  l'embryon  de  poulet.  Arch.  Biol. 
54:189-206. 
22.  OGER, J.,  B.  G.  W.  ARNASON, N.  PANTASlZ, J. 
LEHRICH,  and  M.  YOUNG. 1974. Synthesis  of 
nerve growth factor by L and 3T3 cells in culture. 
Proc.  Natl. Acad. Sci.  U. S. A. 71:1554  1558. 
23.  PANNESE,  E.,  R.  BIANCHI,  B.  CALLtGARIS,  R. 
VENTURA, and E.  R. WEIBEL. 1972. Quantitative 
relationships between nerve  and  satellite cells  in 
spinal ganglia.  An electron microscopical study.  1. 
Mammals. Brain Res. 46:215  234. 
24.  PARTLOW,  L.  M.,  and  M.  G.  LARRASEE. 1971. 
Effects of a  nerve  growth factor, embryonic age 
and  metabolic inhibitors on  synthesis of ribonu- 
cleic  acid  and  protein  in  embryonic  sensory 
ganglia. J. Neurochem.  18:2101  2118. 
25.  SMITH, A. P., S. VAgON, and E. M. SHOOTER. 1968. 
Multiple forms of the nerve growth factor protein 
and its subunits.  Biochemistry.  7:3259-3268. 
26.  STOECKEL, K., and H. THOENEN. 1975. Retrograde 
axonal  transport  of nerve growth  factor:  speci- 
ficity  and  biological  importance.  Brain  Res. 
115:337-341. 
27.  VARON, S., J. NOMURA,  and E. M. SHOOTER. 1967. 
The  isolation of the  mouse nerve  growth  factor 
protein in a high molecular weight form. Biochem- 
istry.  6:2202  2209. 
28.  VARON, S., and C. RAmORr~. 1972. Dissociation of 
chick embryo spinal ganglia and the effects on cell 
yields  by  the  mouse  7S  nerve  growth  factor. 
Neurobiol.  (Biochem. Morphol.). 2:106  122. 
29.  VAROX, S.,  and  C.  RAIBORN. 1972. Dissociation, 
fractionation and culture of chick embryo sympa- 
thetic ganglionic cells. J. Neurocytol.  1:211-221. 
30.  WINICK, M., and R. E. GREEr~BERG. 1967. Chemical 
control of sensory ganglia during a critical period 
of development. Nature (Lond.). 205:180  181. 
HERRUP AND  S[tOOTER  B-Nerve  Growth  Factor Receptor in Development  125 